Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis
Gloria Hernández‐Torres, Mariateresa Cipriano, Erika Hedén, et al.
Angewandte Chemie (2014) Vol. 126, Iss. 50, pp. 13985-13990
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Bioactive lipids, inflammation and chronic diseases
Alessandro Leuti, Domenico Fazio, Marina Fava, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 133-169
Closed Access | Times Cited: 234
Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 229
Endocannabinoids drive the acquisition of an alternative phenotype in microglia
Míriam Mecha, Ana Feliú, Francisco Carrillo‐Salinas, et al.
Brain Behavior and Immunity (2015) Vol. 49, pp. 233-245
Closed Access | Times Cited: 195
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 189
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders
Hui Deng, Weimin Li
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 582-602
Open Access | Times Cited: 138
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
José Luis López-Sendón, Juan García Caldentey, Patricia Trigo Cubillo, et al.
Journal of Neurology (2016) Vol. 263, Iss. 7, pp. 1390-1400
Closed Access | Times Cited: 126
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders
Justin S. Cisar, Olivia D. Weber, Jason R. Clapper, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9062-9084
Open Access | Times Cited: 125
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
G Grabner, Robert Zimmermann, Rudolf Schicho, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 35-46
Open Access | Times Cited: 122
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiù, Mario van der Stelt, Diego Centonze, et al.
Progress in Neurobiology (2017) Vol. 160, pp. 82-100
Open Access | Times Cited: 116
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martín‐Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 103
Cannabinoid signaling in health and disease
Yan Lu, H. D. Anderson
Canadian Journal of Physiology and Pharmacology (2017) Vol. 95, Iss. 4, pp. 311-327
Open Access | Times Cited: 91
Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 25
Open Access | Times Cited: 91
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation
Laura A. McAllister, Christopher R. Butler, Scot Mente, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 7, pp. 3008-3026
Closed Access | Times Cited: 66
The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies
Daniela Călina, Ana Maria Bugă, Mihaela Mitroi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2395-2395
Open Access | Times Cited: 61
Monoglyceride lipase: Structure and inhibitors
Laura Scalvini, Daniele Piomelli, Marco Mor
Chemistry and Physics of Lipids (2015) Vol. 197, pp. 13-24
Open Access | Times Cited: 61
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017)
Carlotta Granchi, Isabella Caligiuri, Filippo Minutolo, et al.
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 12, pp. 1341-1351
Closed Access | Times Cited: 58
Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors
Jumpei Aida, Makoto Fushimi, Tomokazu Kusumoto, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9205-9217
Closed Access | Times Cited: 58
2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination
Ana Feliú, Itziar Bonilla Del Rio, Francisco Carrillo‐Salinas, et al.
Journal of Neuroscience (2017) Vol. 37, Iss. 35, pp. 8385-8398
Open Access | Times Cited: 55
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 4, pp. 1932-1958
Open Access | Times Cited: 53
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Carlotta Granchi, Flavio Rizzolio, Stefano Palazzolo, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 22, pp. 10299-10314
Open Access | Times Cited: 51
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 3, pp. 1340-1354
Open Access | Times Cited: 51
Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase
Lu Wang, Wakana Mori, Ran Cheng, et al.
Theranostics (2016) Vol. 6, Iss. 8, pp. 1145-1159
Open Access | Times Cited: 49
2‐AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs
Míriam Mecha, Ana Feliú, Isabel Machín-Díaz, et al.
Glia (2018) Vol. 66, Iss. 7, pp. 1447-1463
Closed Access | Times Cited: 48
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization
Stefania Butini, Uwe Grether, Kwang‐Mook Jung, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1758-1782
Open Access | Times Cited: 4
Experimentation of Heterocycles (2013‐22) as Potent Pharmacophores in Drug Design of Multiple Sclerosis
Atukuri Dorababu
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top